This scientific webinar addresses molecular mechanisms underlying brain tumour development and their translation into targeted and precision therapeutic strategies, with direct relevance to research and clinical practice. Scientific Programme Highlights Molecular drivers of high-grade gliomas (EGFR, IDH1/2, BRAF, TP53, H3K27M) Epigenetic regulation and tumour heterogeneity Targeted therapy and precision oncology approaches Synthetic lethality and DNA repair vulnerabilities Tu

Plans are in motion to launch a pioneering Photodynamic Therapy Brain Cancer Centre in Scotland, led by The Global Alliance for...

Dr. Philip Boughton of Global Surgical Innovations (GSI) expresses his support for the Global Alliance for Neurosurgical & Brain Cancer...

Nazar Vasyliv recently participated in the 9th World Congress on Cancer Science & Therapy, where he shared his insights on cutting-edge...